Arkolith/Insider Trading/LCTX/Form 4

Culley Brian M

President and CEO, DirectorLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Mar 12, 2026
Net Buying
Open-Market Buys
$24K
Open-Market Sells
$0
Net Open-Market Flow
$24K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Buy(P)15K$1.63$24K256K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-104106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML